摘要:
A process for preparing a compound represented by formula (Y1) or (Y2) [wherein R x is an optionally substituted carbocyclyl lower alkyl, or the like] or a salt thereof, using a novel process for preparing a pyridone derivative represented by formula (X4) [wherein R 1d is hydrogen, halogen, or the like; R 2d is hydrogen, a lower alkyl optionally substituted with substituent E, or the like; R 4d is a lower alkyl optionally substituted with substituent E, or the like; and R 6d is a lower alkyl group optionally substituted with substituent group E].
摘要翻译:使用由式(Y1)或(Y2)表示的吡啶酮衍生物的新方法制备式(Y1)或(Y2)[其中R x为任选取代的碳环基低级烷基等)或其盐的方法 X4)[其中R 1d是氢,卤素等; R 2d是氢,任选被取代基E取代的低级烷基等; R 4d是任选被取代基E取代的低级烷基等; R 6d为任选被取代基组E取代的低级烷基等)。
摘要:
A compound which specifically binds to a receptor of NR1/ NR2B, and is used as a NR2B receptor antagonist is provided. It has been found out that a piperazine derivative represented by the formula (I) binds specifically to a receptor of NR1/NR2B, and is used as a NR2B receptor antagonist. A compound represented by:
wherein R 1 is each independently C1-C3 alkyl or the like, m is an integer of 0 to 4, X is -N(R 4 )-C(=O)-C(=O)-, -N(R 4 )-(CR 5 R 6 ) p -C(=O)-, -N(R 4 )-C(-O)-(CR 7 R 8 ) q - or -C(=O)-N(R 4 )-(CR 7 R 8 ) q -, p and q are each independently an integer of 1 to 3, R 4 , R 5 , R 6 , R 7 and R 8 are each independently a hydrogen atom or lower alkyl, A 1 is benzoxazolinone or the like, and A 2 is optionally substituted phenyl or the like, or a pharmaceutically acceptable salt or a solvate thereof.
摘要:
A process for preparing a compound represented by formula (Y1) or (Y2) [wherein R x is an optionally substituted carbocyclyl lower alkyl, or the like] or a salt thereof, using a novel process for preparing a pyridone derivative represented by formula (X4) [wherein R 1d is hydrogen, halogen, or the like; R 2d is hydrogen, a lower alkyl optionally substituted with substituent E, or the like; R 4d is a lower alkyl optionally substituted with substituent E, or the like; and R 6d is a lower alkyl group optionally substituted with substituent group E].
摘要:
The present invention relates to an agent for treating or preventing disease induced by production, secretion and/or deposition of amyloid β protein, for example, a compound of formula (I), wherein, R 1 , R 2a , R 2b R 3 , R 4a , R 4b , ring A, and dashed line are described in this specification, its pharmaceutically acceptable salt or a solvate thereof.
摘要翻译:本发明涉及用于治疗或预防由淀粉样蛋白2蛋白质的产生,分泌和/或沉积引起的疾病的药剂,例如式(I)化合物,其中R 1,R 2a,R 2b R 3, R 4a,R 4b,环A和虚线在本说明书中描述,其药学上可接受的盐或其溶剂合物。
摘要:
It was found out that the nitrogen-containing heterocyclic derivative represented by the formula (I) specifically binds to a receptor of NR1/NR2B, and is used as a NR2B receptor antagonist. A compound represented by:
wherein Z is N or CR 1 , A 1 is a nitrogen-containing aromatic monocyclic group which is optionally substituted, a nitrogen-containing aromatic fused cyclic group which is optionally substituted etc., A 2 is an aromatic hydrocarbon cyclic group or an aromatic heterocyclic group, each optionally having a substituent, R 1 , R 2 , R a , R b , R c and R d are each independently hydrogen, hydroxy, etc., w is 2 or 3, t is 1 or 2, X is -(CR 3 R 4 )m-, -CO(CR 3 R 4 )n-, -CONR 5 (CR 3 R 4 )n- etc., m is an integer of 1 to 4, n is an integer of 0 to 4, R 3 and R 4 are each independently hydrogen, halogen, hydroxy etc., and R 5 is hydrogen or lower alkyl, or a pharmaceutically acceptable salt, or a solvate thereof.
摘要:
A process for producing an alpha -hydroxyiminophenylacetonitrile represented by general formula [II], (wherein R , R , R and Z are each as defined in the specification) by reacting a crude nitrile containing a phenylacetonitrile represented by general formula [I], (wherein R , R , R and Z are each as defined in the specification) with an alkyl nitrite in the presence of a base, extracting the reaction mixture with water, and neutralizing the separated water layer with an acid. This process enables target alpha -hydroxyiminophenylacetonitriles to be readily produced in a highly pure form in high yield by extracting the reaction mass with water and neutralizing the separated water layer with an acid.
摘要:
A process for producing an α-alkoxyiminophenylacetonitrile represented by general formula [III], (wherein R¹, R², R³ and Y are each as defined in the specification) by reacting an alkali metal salt of an α-hydroxyiminophenylacetonitrile, represented by general formula [I], (wherein R¹, R², Y and A are each as defined in the specification) with a dialkyl sulfate represented by the general formula [II]: (R³)₂SO₄, (wherein R³ is as defined in the specification) in the presence of a phase transfer catalyst in a solvent mixture composed of a hydrocarbon solvent and water. It is possible by using the above catalyst and solvent mixture to inhibit the formation of a nitrone derivative as a by-product to thereby produce a highly pure alkoxyimino compound in a high yield.
摘要:
A process for preparing a compound represented by formula (Y1) or (Y2) [wherein R x is an optionally substituted carbocyclyl lower alkyl, or the like] or a salt thereof, using a novel process for preparing a pyridone derivative represented by formula (X4) [wherein R 1d is hydrogen, halogen, or the like; R 2d is hydrogen, a lower alkyl optionally substituted with substituent E, or the like; R 4d is a lower alkyl optionally substituted with substituent E, or the like; and R 6d is a lower alkyl group optionally substituted with substituent group E].
摘要:
A process for preparing a compound represented by formula (Y1) or (Y2) [wherein R x is an optionally substituted carbocyclyl lower alkyl, or the like] or a salt thereof, using a novel process for preparing a pyridone derivative represented by formula (X4) [wherein R 1d is hydrogen, halogen, or the like; R 2d is hydrogen, a lower alkyl optionally substituted with substituent E, or the like; R 4d is a lower alkyl optionally substituted with substituent E, or the like; and R 6d is a lower alkyl group optionally substituted with substituent group E, or the like].